Feasibility of ReSpace™ Hydrogel to Establish a Stable Cervical-rectal Space

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

October 10, 2023

Study Completion Date

October 10, 2023

Conditions

Uterine Cervical Neoplasms

Interventions

DEVICE

ReSpace™

All of the subjects will be injected with ReSpace™ hydrogel.

Trial Locations (1)

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

collaborator

Shanghai Reunion Biotech Co.,Ltd.

UNKNOWN

lead

Peking Union Medical College Hospital

OTHER